Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives

Diabetes

Volumn 43, Issue 11, 1994, Pages 1304-1310

  Bingley, Polly J ^a   Christie, Michael R ^b   Bonifacio, Ezio ^c   Bonfanti, Ricardo ^a   Shattock, Marion ^c   Fonte, Maria Teresa ^c   Bottazzo, Gian Franco ^c   Gale, Edwin A M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ALGORITHM; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY STUDY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK; SCREENING;

EID: 0028584260     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.11.1304     Document Type: Article

References (20)

1. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
2. Bonifacio E, Bingley PJ, Dean DM, Shattock M, Dunger D, Gale EAM, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
3. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein J, Schatz DA, Schwanz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-1172, 1990
4. Vardi P, Crisa L, Jackson RA: Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 34:93-102, 1991
5. Palmer JP, Asplin CM, demons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetes before insulin treat-ment. Science 222:1337-1339, 1983
6. Baekkeskov S, Aanstoot ILJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richler-Olesen H, de Camiffi P: Identification of the 64K autoantigen in insulin-dependent diabetes as GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
7. Christie MR, Hollands JA, Brown TJ, Michelsen BK, Delovitch TL: Detection of pancreatic islet 64,000 M, autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 92:240-248, 1993
8. Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG: Complement fixing islet cell antibodies in type 1 diabetes: possible monitors of active β-cell damage. Lancet 1:668-672, 1980
9. Bottazzo GF, Gleichman H: Immunology and Diabetes Workshops: report of the First International Workshop on Standardisation of Cytoplasmic Islet Cell Antibodies. Diabetologia 29:125-126, 1986
10. Bonifacio E, Lemmark A, Dawkins RL: Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106:83-88, 1988
11. Kurtz AB, DiSilvio L, Bosi E: The determination of detection limits for insulin antibody assays. Diabetologia 31:395-399, 1988
12. Christie MR, Brown TJ, Cassidy D: Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues: evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35:380-384, 1992
13. Christie MR, Tun RYM, Lo SSS, Cassidy D, Brown TJ, Hollands J, Shattock M, Bottazzo GF, Leslie RDG: Antibodies to GAD and tryptic fragments of the islet 64K antigen as distinct markers for development of IDDM: studies with identical twins. Diabetes 41:782-787, 1992
14. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL: Distinct antibody specificities to a 64 kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172:789-795, 1990
15. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385-388, 1992
16. Gianani R, Pugliese A, Bonner-Weir S, Schiffrin A, Soeldner JS, Erlich HA, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS: Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 41:347-353, 1992
17. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38:1320-1325, 1989
18. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF: Antibodies to islet 37-kDa antigen but not to glutamate decarboxylase discriminate rapid progression to insulin-dependent diabetes mellitus in endocrine autoimmunity. Diabetes. In press
19. Harrison LC: Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13:348-352, 1992
20. Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM: Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16:45-50, 1993